BEST3 Trial
http://www.best3trial.org/
The BEST3 Trial is a Cluster Randomised Controlled Trial comparing the Cytosponge™-TFF3 test with usual care to facilitate the diagnosis of oesophageal pre-cancer in primary care. The following types of the samples are collected as part of the Trial methodology: • Cytosponge™ samples • Saliva samples (TFF3-positive Cytosponge™ cases) • Endoscopic biopsy samples including gastric cardia and clinically-indicated oesophageal biopsies Cytosponge™ and endoscopic biopsy samples will be further processed into FFPE blocks and tissue sections.
Existing samples:
- Fit and well (finding)
Contact Information
- Email:
- bm482@medschl.cam.ac.uk
- Address:
-
Cambridge University Hospitals NHS Foundation Trust
Addenbrookes Hospital, Hills Rd
Cambridge
Cambridgeshire
CB2 0QQ
England
Last Updated: 04/05/2020
Annual Statistics
| Year | Access Requests Received | Access Requests Approved | ||||
|---|---|---|---|---|---|---|
| Internal | External | Commercial | Internal | External | Commercial | |
| 2015 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2017 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 1 | 1 | 0 | 1 | 1 |
| 2021 | N/A | N/A | N/A | N/A | N/A | N/A |
| 2022 | N/A | N/A | N/A | N/A | N/A | N/A |